a) Bioconversions with
0.5 gCDW L-1 of cells in Erlenmeyer
flasks, 10 min assay time
b) Addition of 9.2 mM cyclohexane (180 µM in aqueous
phase), activities correspond to the first 10 min in the experiments
shown in Figures 3BD, 4B, S3B.
c) Maximal activity obtained by testing different
cyclohexanol concentrations (see also Figure 3F)
d) Addition of 5 mM substrate
e) Average values for the sum of ε-CL and 6HA formed
including standard deviations of two independent biological replicates.
Table 3: Comparison of biocatalytic PCL precursor synthesis
approaches.